Sevelamercarbonate? , 845273-93-0
CAS NO.：845273-93-0
Empirical Formula: C7H14ClNO4
Molecular Weight: 211.64
MDL number: MFCD18904375
EINECS: 682-521-9
| Pack Size | Price | Stock | Quantity |
| 100g | RMB353.60 | In Stock |
|
| 500g | RMB1248.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| storage temp. | Room Temperature, under inert atmosphere |
| solubility | <4.74mg/mL in DMSO |
| form | Solid |
| color | White to Pale Beige |
| InChI | InChI=1S/C3H5ClO.C3H7N.CH2O3/c4-1-3-2-5-3;1-2-3-4;2-1(3)4/h3H,1-2H2;2H,1,3-4H2;(H2,2,3,4) |
| InChIKey | PADGNZFOVSZIKZ-UHFFFAOYSA-N |
| SMILES | C(O)(O)=O.C(C1OC1)Cl.C(=C)CN |
Description and Uses
Sevelamer carbonate (SC) is a non-absorbed phosphate binding crosslinked polymer, with the same polymeric structure as sevelamer hydrochloride, in which carbonate replaces chloride as the counterion. SC has been found to have the same safety and efficacy profile as Sevelamer HCl in HD patients.
Sevelamer carbonate(Renvela) is a nonaluminum, non-calcium-basedphosphorus binder that traps phosphorus in the bowel through ion exchange and hydrogen binding. This drug replaced sevelamer hydrochloride(Renagel) and has an advantage of not generating an acid load, as its precursor, sevelamer hydrochloride, did. It also has the advantage of lowering LDL cholesterol due to gut binding of bile acids.
Control of serum phosphorus in patients with chronic kidney disease (phosphate binder).
